Nurmi H - Search Results

1

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.

Mattila E, Uusitalo-Seppälä R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, Moilanen V, Salminen K, Seppälä M, Mattila PS, Anttila VJ, Arkkila P. Mattila E, et al. Among authors: nurmi h. Gastroenterology. 2012 Mar;142(3):490-6. doi: 10.1053/j.gastro.2011.11.037. Epub 2011 Dec 7. Gastroenterology. 2012. PMID: 22155369

2

Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.

Rautiainen H, Salomaa V, Niemelå S, Karvonen AL, Nurmi H, Isoniemi H, Färkkilä M. Rautiainen H, et al. Among authors: nurmi h. Scand J Gastroenterol. 2007 Nov;42(11):1347-53. doi: 10.1080/00365520701396034. Scand J Gastroenterol. 2007. PMID: 17918011

3

Gene expression of group II phospholipase A2 in intestine in Crohn's disease.

Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Nevalainen TJ. Haapamäki MM, et al. Among authors: nurmi h. Am J Gastroenterol. 1999 Mar;94(3):713-20. doi: 10.1111/j.1572-0241.1999.00941.x. Am J Gastroenterol. 1999. PMID: 10086656

4

Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis.

Rautiainen H, Färkkilä M, Neuvonen M, Sane T, Karvonen AL, Nurmi H, Kärkkäinen P, Neuvonen PJ, Backman JT. Rautiainen H, et al. Among authors: nurmi h. Aliment Pharmacol Ther. 2006 Dec;24(11-12):1545-52. doi: 10.1111/j.1365-2036.2006.03155.x. Aliment Pharmacol Ther. 2006. PMID: 17206943 Free article. Clinical Trial.

5

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.

Färkkilä M, Karvonen AL, Nurmi H, Nuutinen H, Taavitsainen M, Pikkarainen P, Kärkkäinen P. Färkkilä M, et al. Among authors: nurmi h. Hepatology. 2004 Dec;40(6):1379-86. doi: 10.1002/hep.20457. Hepatology. 2004. PMID: 15565569 Clinical Trial.

6

Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21.

Paavola P, Heliö T, Kiuru M, Halme L, Turunen U, Terwilliger J, Karvonen AL, Julkunen R, Niemelä S, Nurmi H, Färkkilä M, Kontula K. Paavola P, et al. Among authors: nurmi h. Eur J Hum Genet. 2001 May;9(5):328-34. doi: 10.1038/sj.ejhg.5200626. Eur J Hum Genet. 2001. PMID: 11378820

7

Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial.

Rautiainen H, Kärkkäinen P, Karvonen AL, Nurmi H, Pikkarainen P, Nuutinen H, Färkkilä M. Rautiainen H, et al. Among authors: nurmi h. Hepatology. 2005 Apr;41(4):747-52. doi: 10.1002/hep.20646. Hepatology. 2005. PMID: 15754377 Clinical Trial.

8

Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.

Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Kallajoki M, Nevalainen TJ. Haapamäki MM, et al. Among authors: nurmi h. Gut. 1997 Jan;40(1):95-101. doi: 10.1136/gut.40.1.95. Gut. 1997. PMID: 9155583 Free PMC article.

9

Elevated group II phospholipase A2 mass concentration in serum and colonic mucosa in Crohn's disease.

Haapamäki MM, Grönroos JM, Nurmi H, Söderlund K, Peuravuori H, Alanen K, Nevalainen TJ. Haapamäki MM, et al. Among authors: nurmi h. Clin Chem Lab Med. 1998 Oct;36(10):751-5. doi: 10.1515/CCLM.1998.133. Clin Chem Lab Med. 1998. PMID: 9853800

10

Phospholipase A2 in serum and colonic mucosa in ulcerative colitis.

Haapamäki MM, Grönroos JM, Nurmi H, Irjala K, Alanen KA, Nevalainen TJ. Haapamäki MM, et al. Among authors: nurmi h. Scand J Clin Lab Invest. 1999 Jul;59(4):279-87. doi: 10.1080/00365519950185643. Scand J Clin Lab Invest. 1999. PMID: 10463466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters